Profile
Yaping Shou worked as an Executive Medical Director at Millennium Pharmaceuticals, Inc. from 2011 to 2018, and as a Chief Medical Officer at Trillium Therapeutics ULC from 2018 to 2020.
Dr. Shou holds a doctorate degree from the University of Pennsylvania, Drexel University College of Medicine, and Zhejiang University School of Medicine.
Former positions of Yaping Shou
| Companies | Position | End |
|---|---|---|
| TRILLIUM THERAPEUTICS | Chief Tech/Sci/R&D Officer | 2020-11-01 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2018-05-31 |
Training of Yaping Shou
| University of Pennsylvania | Doctorate Degree |
| Drexel University College of Medicine | Doctorate Degree |
| Zhejiang University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Yaping Shou
